Reco Medical LTD is a spinout company from Imperial College London formed by
the team who has been working on the wireless sensing for last 12 years. The core
technology has been developed by the team, mainly supported by the Department of Health and Social Care and the Wellcome Trust through HICF (Health Innovation Challenge Fund) £5 Million research grant.
The technology attracted commercial interest and a start-up, Cardian Limited, was founded by the team in 2016 for cardiovascular applications. Reco Medical was formed in 2019 to commercialize the wireless intracranial pressure (ICP) monitoring system.
We are delighted that we have been awarded Innovate UK Smart Grant £500K (2020) to complete chronic animal trial and prepare for first-in-human trial in 2022.
Reza has been doing research at the interface of engineering/physics with medicine for eighteen years at Imperial College. His research aims to address unmet needs in medical devices that may improve the quality of life of patients across the world.
His research has resulted in 11 patents and attracted significant commercial investment and public fundings (Wellcome Trust, NIHR, MRC). He has been leading and managing industrial partners to ensure that sensor and interrogator developments are consistent with quality and regulatory requirements. He also consults for several SMEs in medical device R&D.
Longfang has participated in the project at Imperial College since 2014. He specialises in RF communication for implantable devices, sensor characterization, system verification and validation, and collaborative development with institutes and industrial partners.
Since May 2019, he has been driving the commercialization of ICP monitoring system. With a background of academic researcher and various industrial roles (control and software engineer, telecommunication project manager, founder and director of startup company), he, together with core team members, will execute and accomplish the goals and objectives of Reco Medical.
Dipankar is a professor of Practice (Neurosurgery) at the Department of Brain Sciences, Imperial College and consultant neurosurgeon at Charing Cross Hospital.
His clinical and research interests cover brain tumours, Parkinson's disease surgery, chronic pain surgery, spinal disorders, and trauma. He has been involved in the project since inception and strong supporter of the potential applicability of the technology for reducing infection risk and hospitalisations as well as providing better treatment for neurological chronic diseases.
Dave is a successful Medical Device Entrepreneur and Business Development Specialist.
He has a wide-ranging track record delivering high-performing products to healthcare markets and creating inventive start-ups. He organises Medical Device Entrepreneurship courses as a faculty member at the University of Cambridge, with focus on digital heath opportunities and physician-driven innovation. He blends a strong academic background with practical business problem-solving skills, demonstrated capable quickly appraising business and product issues then implementing solutions without undue cost or delay.
Rui is an expert in electronics R&D, Embedded Systems, FPGA Firmware Design, PCB Design and Signal Processing.
He has been working at the University of Oxford as a Senior Electronics Engineer since 2007. He led and participated electronics systems research and development for applications in Physics, Chemistry, Computer Sciences and Biotech. He is also highly experienced in design cycle of electronics from R&D to commercialization.
Chris initiated development of SAW sensor for implantable medical device in 2007.
He has worked on non-invasive or minimally invasive physiological monitoring systems for 44 years.
Ursula was former Medtronic VP CRDM Research Technology and New Therapies and Diagnostics.
She is working with startup companies to develop international and national strategies as well as tactical plans for introduction of new medical devices in the European market. She has been a member of research steering group of the R&D for more than 10 years.
Xiaofeng is a Senior Manager at Deloitte's Strategy Consulting practice and specialises in the life sciences and healthcare industry.
He has over ten years' experience with a focus on marketing strategy and operational build-up for MedTech and Biotech companies.